Redeye initiates coverage of Initiator Pharma, a Danish biotech company, primarily developing CNS-targeted drugs for Erectile Dysfunction (ED). The three exciting compounds in its clinical pipeline offer a compelling case, bolstered by strong management, a newly secured financial runway, and a unique niche.

Link to the analysis